Print

Purpose

Avoidant/restrictive food intake disorder (ARFID) is a serious and impairing eating disorder - occurring in up to 4% of adults - for which most individuals do not have access to treatment. The proposed study aims to develop and test a mobile app to scale delivery of cognitive-behavioral therapy for ARFID. Knowledge gained will contribute to the development of a clinically accessible, scalable, inexpensive treatment for ARFID, a highly impairing disorder for which there are significant barriers to care access.

Condition

Eligibility

Eligible Ages
Between 18 Years and 55 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Current avoidant/restrictive food intake disorder based on DSM-5 criteria 2. Must not have completed face-to-face CBT-AR at the Eating Disorders Clinical and Research Program at Massachusetts General Hospital 3. Ability to speak, write, and understand English 4. Residence in the United States 5. Access to an internet-connected smartphone device

Exclusion Criteria

  1. Underweight status (i.e., BMI < 18.5 kg/m2) 2. Complete lack of oral intake or dependence on supplemental feeding 3. Feeding or eating disorder other than ARFID 4. Any comorbid clinically significant disorder that would require attention beyond the study treatment 6. Medical instability requiring inpatient care according to the American Psychiatric Association 2023 treatment guidelines for eating disorders 7. Medical history of intellectual disability 8. Illiteracy

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
mCBT-AR
  • Behavioral: mCBT-AR
    mCBT-AR is an 8-week virtual treatment for avoidant/restrictive food intake disorder delivered via mobile application
No Intervention
Usual care

Recruiting Locations

Massachusetts General Hospital
Boston, Massachusetts 02114

More Details

Status
Recruiting
Sponsor
Massachusetts General Hospital

Study Contact

Paraskevi Kambanis, PhD
617-724-0799
pkambanis@mgh.harvard.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.